Core Insights - Klotho Neurosciences, Inc. will present at the 2026 Biotech Showcase in San Francisco on January 13, 2026, at 11:30 AM PT [1] - The company focuses on developing innovative, disease-modifying cell and gene therapies targeting neurodegenerative and age-related disorders [3] Company Overview - Klotho Neurosciences, Inc. specializes in therapies derived from a patented form of the "anti-aging" human Klotho gene (s-KL) [3] - The current portfolio includes proprietary cell and gene therapy programs utilizing DNA and RNA as therapeutics, along with genomics-based diagnostic assays [3] - The management team consists of experienced individuals and advisors in biopharmaceutical product development and commercialization [3] Investor Engagement - The company will be available for one-on-one meetings with investors and potential partners during the Biotech Showcase [2]
Klotho Neurosciences to Present at the Biotech Showcase 2026